 "Govt creating 30-day stock of key Covid drugs ahead of anticipated 3rd wave")
Ahead of the anticipated third wave, India is trying to build a buffer stock or inventory of essential Covid-19 medicines like remdesivir and favipiravir, besides common drugs and supplements like paracetamol, antibiotics, and vitamins. According to industry sources, the plan is to have a 30-day stock for key drugs like remdesivir, a shortage of which was witnessed during the first two waves.
“The Centre is planning to procure 5 million vials of remdesivir ahead of the third wave. What’s better is that this time, the government is paying us in advance,” said a senior executive of a Mumbai-based pharma player which
